1. India Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - Specialty & Generic
Aarti Pharmalabs Limited

Aarti Pharmalabs Limited

AARTIPHARM.NS
Aarti Pharmalabs LimitedIN flagNational Stock Exchange of India
699.50
INR
-5.85
- -
63.42BMarket Cap

Total Valuation

Aarti Pharmalabs Limited carries a market capitalization of 63.42B, placing it among publicly traded companies globally. Its enterprise value stands at 61.12B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap63.42B
Enterprise Value61.12B

Share Statistics

Aarti Pharmalabs Limited currently has 90.66M shares outstanding.

Shares Outstanding90.66M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

Aarti Pharmalabs Limited trades at a trailing price-to-earnings ratio of 28.78. The price-to-sales ratio is 2.95, and the price-to-book ratio stands at 118.40.

PE Ratio28.78
PS Ratio2.95
PB Ratio118.40
P/TBV Ratio2.68
P/FCF RatioN/A
P/OCF RatioN/A

Enterprise Valuation

On an enterprise value basis, Aarti Pharmalabs Limited trades at an EV/EBITDA multiple of 20.51 and an EV/FCF ratio of 173.76. The EV/Sales ratio of 3.36 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 20.51 provides insight into valuation relative to core operating earnings.

EV / Sales3.36
EV / EBITDA20.51
EV / EBIT20.51
EV / FCF173.76

Financial Position

Aarti Pharmalabs Limited maintains a current ratio of 1.49, meaning it holds 1.5x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 35.51, indicating elevated leverage, while an interest coverage ratio of 6.35 demonstrates adequate ability to service its debt obligations.

Current Ratio1.49
Quick Ratio0.01
Debt / Equity35.51
Debt / EBITDA2.53
Interest Coverage6.35

Financial Efficiency

Aarti Pharmalabs Limited posts a return on equity of 26.38 and a return on invested capital of 8.45.

Return on Equity (ROE)26.38
Return on Assets (ROA)5.84
Return on Invested Capital (ROIC)8.45
Return on Capital Employed (ROCE)17.12
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover1.36

Taxes

Over the trailing twelve months, Aarti Pharmalabs Limited has paid 621.90M in income taxes, reflecting an effective tax rate of 25.01.

Income Tax621.90M
Effective Tax Rate25.01

Stock Price Statistics

Aarti Pharmalabs Limited's stock has declined approximately -22.19998% over the past 52 weeks. The 50-day moving average sits at 690.19, while the 200-day moving average is 727.74.

Beta (5Y)N/A
52-Week Price Change-22.19998%
50-Day Moving Average690.19
200-Day Moving Average727.74
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Aarti Pharmalabs Limited generated 18.19B in revenue and converted that into 1.87B in net income, yielding earnings per share of 20.57. EBITDA reached 2.98B, while operating income came in at 2.98B.

Revenue18.19B
Gross Profit9.85B
Operating Income2.98B
Pretax Income2.49B
Net Income1.87B
EBITDA2.98B
EBIT2.98B
Earnings Per Share (EPS)20.57

Balance Sheet

Aarti Pharmalabs Limited holds 96.16M in cash and equivalents against 7.54B in total debt, resulting in a net debt position of 6.77B. Total book value stands at 453.29M, with working capital of 4.60B providing operational flexibility.

Cash & Cash Equivalents96.16M
Total Debt7.54B
Net Debt6.77B
Equity (Book Value)453.29M
Book Value Per Share5.00
Working Capital4.60B

Margins

Aarti Pharmalabs Limited operates with a gross margin of 54.11, reflecting its pricing power and cost economics. The operating margin of 16.38 and net profit margin of 10.25 provide insight into operational efficiency.

Gross Margin54.11
Operating Margin16.38
Pretax Margin13.67
Profit Margin10.25
EBITDA Margin16.38

Scores

Aarti Pharmalabs Limited posts an Altman Z-Score of 3.37, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score3.37